Summary:
Summary Statement of Deficiencies D5305 TEST REQUEST CFR(s): 493.1241(c) The laboratory must ensure the test requisition solicits the following information: (1) The name and address or other suitable identifiers of the authorized person requesting the test and, if appropriate, the individual responsible for using the test results, or the name and address of the laboratory submitting the specimen, including, as applicable, a contact person to enable the reporting of imminently life threatening laboratory results or panic or alert values. (2) The patient's name or unique patient identifier. (3) The sex and age or date of birth of the patient. (4) The test(s) to be performed. (5) The source of the specimen, when appropriate. (6) The date and, if appropriate, time of specimen collection. (7) For Pap smears, the patient's last menstrual period, and indication of whether the patient had a previous abnormal report, treatment, or biopsy. (8) Any additional information relevant and necessary for a specific test to ensure accurate and timely testing and reporting of results, including interpretation, if applicable. This STANDARD is not met as evidenced by: Through a review of the laboratory policy for Gynecologic Pap Test, a review of ten electronic requisitions for patients with Pap smears requested, and interviews with laboratory staff, it was determined that one of ten Pap requisitions did not include the date of the last menstrual period (LMP). A. A review of the "Special Instructions" section of the Gynecologic Pap Test policy revealed, "Include date of birth, Social Security number (or other identification number), previous malignancy, drug therapy, radiation therapy, last menstrual period (LMP), postmenopausal patient,..." B. Through review of ten electronic requisitions for patients with Pap smears requested, one of ten requisitions failed to include the LMP. The requisition, dated 4/4/2024, was for patient #14522668 (a 29 year old female). The requisition did not include the date Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- of the LMP nor did it include a line where an LMP could be documented. C. In an interview, at 12:40 on 4/18/2024, the Cytology General Supervisor (as listed on the form CMS-209) confirmed the lack of LMP on the requisition listed above. D6107 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(15) The laboratory director must specify, in writing, the responsibilities and duties of each consultant and each supervisor, as well as each person engaged in the performance of the preanalytic, analytic, and postanalytic phases of testing, that identifies which examinations and procedures each individual is authorized to perform, whether supervision is required for specimen processing, test performance or result reporting and whether supervisory or director review is required prior to reporting patient test results. This STANDARD is not met as evidenced by: Based upon review of personnel records, lack of documentation, and interview it was determined that the laboratory director failed to specify in writing the examinations and procedures that personnel are authorized to perform for four of four testing personnel for which records were presented. Findings follow: A. Upon request, the laboratory was unable to provide a written authorization to perform procedures signed by the laboratory director for four of four testing personnel. B. In an interview on 4/18 /24 at 1:27 p.m., the general supervisor confirmed there were no written authorizations to perform testing, signed by the laboratory director. -- 2 of 2 --